Ventyx Biosciences, Inc.

Contributing Author

Recent Articles by Ventyx Biosciences, Inc.

Oct-22	Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors VTYX GlobeNewswire
Aug-27	Ventyx Biosciences to Participate in Three Upcoming Investor Conferences VTYX GlobeNewswire
Aug-07	Ventyx Biosciences Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Progress VTYX GlobeNewswire
Jun-17	Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson's Disease VTYX GlobeNewswire
May-28	Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference VTYX GlobeNewswire
May-08	Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress VTYX GlobeNewswire